We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

May 14, 2019

ESOC-2019

THE INCIDENCE, SEVERITY AND RECOVERY OF APHASIA FOLLOWING ACUTE STROKE IN A TERTIARY HOSPITAL

;

incidence

aphasia

acute

stroke

Abstract

22

Views

22

Views

Abstract

Fullscreen

thumbnail

Keywords

incidence

aphasia

acute

stroke

Abstract

Background: Aphasia is present in about 30% of patients in the acute setting following stroke (1). However, recent advancements in acute stroke management might have altered the frequency of post-stroke aphasia. Aim: The aim of this study is to re-estimate the incidence, severity and recovery of aphasia following stroke in the acute setting in a tertiary hospital. Methods: All patients admitted to the Stroke Unit of the Ghent University Hospital following a first stroke are enrolled in a prospective observational study. Patients receive standard acute stroke care, including the use of reperfusion therapies (IV thrombolysis, IA thrombectomy), as indicated. The presence of aphasia is confirmed based on the National Institutes of Health Stroke Scale (NIHSS) reported by the attending neurologists at hospital admission, after acute stroke care and at day 7. Additionally, a speech-language pathologist performs a bedside language screening and standardized assessments including ScreeLing and BNT. Preliminary results: Since 10 March 2018, 93 of 125 consecutively enrolled first strokes received acute care within 48 hours post-stroke at Ghent University Hospital. Based on the NIHSS score, aphasia was present in 23.3% (95%CI, 15.8 – 33.1) of patients at hospital admission. After acute stroke care, the incidence of aphasia was 14.1% (95%CI, 8.5 – 22.7) and 15.1% (95%CI, 9.2 – 23.7) according to the bedside screening. In 12.4% (95%CI, 7 – 20.8) of patients, aphasia persisted at day 7 (5.6% mild-moderate, 4.5% severe and 2.2% global aphasia). Conclusion: These preliminary results indicate a decreased aphasia frequency following acute stroke in a tertiary hospital. Trial registration: Clinicaltrials.gov: NCT03472625, registered since 05/03/2018

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.